Newton Biocapital Fund

Newton Biocapital Fund is rated 3 out of 5 in the category venture capital & private equity. Read and write reviews about Newton Biocapital Fund. Newton Biocapital is a Venture Capital Fund incorporated in Belgium, focused on financing biotech and life science projects in the "core of Europe"​ (B, NL, D, F) and Japan for the prevention and treatment of chronic diseases. Our mission is to support the creation of innovative but affordable solutions that will greatly improve the quality of life of patients suffering from chronic diseases. Our approach as lead investor is to support promising start-up projects as well as neglected or undervalued late-stage projects, in order to mitigate the risks and to create investor value. The leadership team consists of specialists with long-standing management and investor experience who coach bio-entrepreneurs through the development stages of their projects As lead investor, we prepare the creation of world leaders by identifying the most valuable IP. Part of our unique expertise is working with management to redesign clinical approaches in order to create the proof of concept as early as possible to demonstrate the breakthrough potential of the science. Having a strong proof of concept then attracts potential buyers. This model is synergistic with university and public funds.